Migergot NDC 0713-0166

NDC codes

FDA NDC Directory

Product NDC (as listed)0713-0166Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00713-0166Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0713-0166-12	00713016612	12 SUPPOSITORY in 1 BOX (0713-0166-12)Marketed from Oct 30, 1983

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Migergot
Generic name (nonproprietary): ergotamine tartrate and caffeine
Active ingredients: Ergotamine tartrate — 2 mg/1Caffeine — 100 mg/1
Dosage form: Suppository
Route: Rectal
Labeler: Cosette Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 086557
Marketing start: Oct 30, 1983
Listing expires: Dec 31, 2026
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)Ergotamines (Chemical structure)Xanthines (Chemical structure)
Identifiers: Product ID 0713-0166_ee9c58f6-c353-2cf3-e053-2a95a90a3f5eSPL ID ee9c58f6-c353-2cf3-e053-2a95a90a3f5eSPL set ID 3a31ad0c-7bdd-544b-f5df-a99d04cf541cRxCUI 1293508, 1293639UNII MRU5XH3B48, 3G6A5W338E
Pharmacologic class: Central Nervous System Stimulant; Ergotamine Derivative; Methylxanthine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400713016612 followed by a unit qualifier and the quantity

Package 00713-0166-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 29, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Ergotamine Tartrate and Caffeine Indicated as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants or so-called “histaminic cephalalgia”.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)